34 related articles for article (PubMed ID: 26636525)
1. Serum ghrelin is associated with risk of colorectal adenocarcinomas in the ATBC study.
Murphy G; Cross AJ; Dawsey SM; Stanczyk FZ; Kamangar F; Weinstein SJ; Taylor PR; Männistö S; Albanes D; Abnet CC; Freedman ND
Gut; 2018 Sep; 67(9):1646-1651. PubMed ID: 28814486
[TBL] [Abstract][Full Text] [Related]
2. In vivo biomarkers for targeting colorectal neoplasms.
Hsiung PL; Wang T
Cancer Biomark; 2008; 4(6):329-40. PubMed ID: 19126961
[TBL] [Abstract][Full Text] [Related]
3. Rapidly Rising Serum Creatinine in a Patient With Colorectal Adenocarcinoma and Eosinophilia: A Quiz.
Banjongjit A; Ratanatharathorn V; Mahanupap P; Mitarnun W
Am J Kidney Dis; 2024 Feb; 83(2):A14-A17. PubMed ID: 38246718
[No Abstract] [Full Text] [Related]
4. Activin A Causes Muscle Atrophy through MEF2C-Dependent Impaired Myogenesis.
Loumaye A; Lause P; Zhong X; Zimmers TA; Bindels LB; Thissen JP
Cells; 2022 Mar; 11(7):. PubMed ID: 35406681
[TBL] [Abstract][Full Text] [Related]
5. Profiling Activins and Follistatin in Colorectal Cancer According to Clinical Stage, Tumour Sidedness and Smad4 Status.
Refaat B; Zekri J; Aslam A; Ahmad J; Baghdadi MA; Meliti A; Idris S; Sultan S; Alardati H; Saimeh HA; Alsaegh A; Alhadrami M; Hamid T; Naeem ME; Elsamany SA
Pathol Oncol Res; 2021; 27():1610032. PubMed ID: 34867090
[TBL] [Abstract][Full Text] [Related]
6. TGFβ and activin A in the tumor microenvironment in colorectal cancer.
Zessner-Spitzenberg J; Thomas AL; Krett NL; Jung B
Gene Rep; 2019 Dec; 17():. PubMed ID: 32154442
[TBL] [Abstract][Full Text] [Related]
7. Increased stiffness of the tumor microenvironment in colon cancer stimulates cancer associated fibroblast-mediated prometastatic activin A signaling.
Bauer J; Emon MAB; Staudacher JJ; Thomas AL; Zessner-Spitzenberg J; Mancinelli G; Krett N; Saif MT; Jung B
Sci Rep; 2020 Jan; 10(1):50. PubMed ID: 31919369
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
[TBL] [Abstract][Full Text] [Related]
9. Perspectives of small molecule inhibitors of activin receptor‑like kinase in anti‑tumor treatment and stem cell differentiation (Review).
Cui X; Shang S; Lv X; Zhao J; Qi Y; Liu Z
Mol Med Rep; 2019 Jun; 19(6):5053-5062. PubMed ID: 31059090
[TBL] [Abstract][Full Text] [Related]
10. Activin A induces apoptosis of mouse myeloma cells via the mitochondrial pathway.
Zhang Y; Qi Y; Zhao Y; Sun H; Ge J; Liu Z
Oncol Lett; 2018 Feb; 15(2):2590-2594. PubMed ID: 29434978
[TBL] [Abstract][Full Text] [Related]
11. Circulating Activin A predicts survival in cancer patients.
Loumaye A; de Barsy M; Nachit M; Lause P; van Maanen A; Trefois P; Gruson D; Thissen JP
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):768-777. PubMed ID: 28712119
[TBL] [Abstract][Full Text] [Related]
12. Activin A regulates activation of mouse neutrophils by Smad3 signalling.
Qi Y; Ge J; Ma C; Wu N; Cui X; Liu Z
Open Biol; 2017 May; 7(5):. PubMed ID: 28515224
[TBL] [Abstract][Full Text] [Related]
13. Commentary: Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer.
Bauer J; Staudacher JJ; Krett NL; Jung B
J Rare Dis Res Treat; 2016; 1(1):43-45. PubMed ID: 27738666
[No Abstract] [Full Text] [Related]
14. Activin A as a novel biomarker for colorectal adenocarcinoma in humans.
Wu S; Qi Y; Niu LM; Xie DX; Cui XL; Liu ZH
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(22):4371-8. PubMed ID: 26636525
[TBL] [Abstract][Full Text] [Related]
15. Activins and their related proteins in colon carcinogenesis: insights from early and advanced azoxymethane rat models of colon cancer.
Refaat B; El-Shemi AG; Mohamed AM; Kensara OA; Ahmad J; Idris S
BMC Cancer; 2016 Nov; 16(1):879. PubMed ID: 27835986
[TBL] [Abstract][Full Text] [Related]
16. The role of neurotensin as a novel biomarker in the endoscopic screening of high-risk population for developing colorectal neoplasia.
Kontovounisios C; Qiu S; Rasheed S; Darzi A; Tekkis P
Updates Surg; 2017 Sep; 69(3):397-402. PubMed ID: 28560510
[TBL] [Abstract][Full Text] [Related]
17. Comparison of colorectal neoplastic polyps and adenocarcinoma with regard to NLR and PLR.
Emir S; Aydin M; Can G; Bali I; Yildirim O; Öznur M; Yildiz ZD; Sözen S; Gürel A
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3613-8. PubMed ID: 26502851
[TBL] [Abstract][Full Text] [Related]
18. Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears.
de Noo ME; Tollenaar RA; Deelder AM; Bouwman LH
World J Gastroenterol; 2006 Nov; 12(41):6594-601. PubMed ID: 17075970
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
